Legal Representation
Attorney
Jenifer deWolf Paine
USPTO Deadlines
Next Deadline
81 days remaining
NOA E-Mailed - SOU Required
Due Date
April 08, 2026
Extension Available
Until October 08, 2026
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 9, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 9, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 8, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 8, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 2, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 2, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 2, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 19, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Nov 20, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Oct 8, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 13, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 13, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 24, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 2, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 19, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 11, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 11, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jan 11, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Dec 16, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 16, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer
Classification
International Classes
005